Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The hypothesis of this study is that the improvement of Numeric Rating Scale (NRS) for Pain at the end of the study will be greater in the Wet Cupping Treatment group than in the Waiting Control group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Wet Cupping | Experimental |
| |
| Waiting Control | No Intervention | They can't use any other specific treatment except exercises and behavior modification (we'll offer a brochure which includes exercise method and directions about behavior modifications). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Wet Cupping | Device | Wet cupping (Seongho trade & company, Korea) will be practiced at two selected points (among the 6 acupoints, left or right BL23, BL24, BL25) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Numeric Rating Scale (NRS) for pain | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| Measure | Description | Time Frame |
|---|---|---|
| Present Pain Intensity Scale of the McGill Pain Questionaire (PPI) | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation | |
| Oswestry Disability Questionnaire (ODQ) | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome).
Patients who are inappropriate to the wet cupping treatment.
Patients who have experiences of wet cupping treatment during last 3 months.
Patients who have had treatment for low back pain during last 2 weeks.
Patients who are in pregnancy or have plan to conception.
Patients who have vertebra surgery or have plan of surgery.
Patients who are inappropriate to join this trial judged by the radiologists or specialists.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sun-mi Choi, Doctor | Korea Institute of Oriental Medicine (KIOM) | Study Chair |
| Jong-In Kim, Doctor | Korea Institue of Oriental Medicine (KIOM) | Study Director |
| Tae-hun Kim, Doctor | Korea Institue of Oriental Medicine (KIOM) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Korea Institue of Oriental Medicine (KIOM), Doonsan Oriental Hospital of Daejeon University | Daejeon | Chungchong | 302-869 | South Korea |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21663617 | Derived | Kim JI, Kim TH, Lee MS, Kang JW, Kim KH, Choi JY, Kang KW, Kim AR, Shin MS, Jung SY, Choi SM. Evaluation of wet-cupping therapy for persistent non-specific low back pain: a randomised, waiting-list controlled, open-label, parallel-group pilot trial. Trials. 2011 Jun 10;12:146. doi: 10.1186/1745-6215-12-146. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017116 | Low Back Pain |
| ID | Term |
|---|---|
| D001416 | Back Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000082 | Acetaminophen |
| ID | Term |
|---|---|
| D000083 | Acetanilides |
| D000813 | Anilides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D000814 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Acetaminophen | Drug | Acetaminophen 500 mg tablets will be offered to both of the wet cupping group and waiting group for relieving severe pain. |
|
| Medication Quantification Scale (MQS) | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| General Assessment of Doctors and Subjects | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| Safety measurement | study group: at base line, post-treatment, 4 weeks later after allocation; control group: at base line, 4 weeks later after allocation |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| Aniline Compounds |
| D000588 | Amines |